Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1813354622;54623;54624 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
N2AB1649249699;49700;49701 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
N2A1556546918;46919;46920 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
N2B906827427;27428;27429 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
Novex-1919327802;27803;27804 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
Novex-2926028003;28004;28005 chr2:178604290;178604289;178604288chr2:179469017;179469016;179469015
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCC
  • RefSeq wild type template codon: GGG
  • Domain: Fn3-19
  • Domain position: 69
  • Structural Position: 99
  • Q(SASA): 0.314
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/L None None 0.669 N 0.413 0.435 0.577797438266 gnomAD-4.0.0 2.08359E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 3.78673E-05
P/S rs532354607 None 0.454 N 0.346 0.27 0.301789629655 gnomAD-4.0.0 2.10634E-06 None None None None N None 0 0 None 0 0 None 0 0 3.66666E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.1066 likely_benign 0.1057 benign -1.052 Destabilizing 0.454 N 0.363 neutral N 0.472067013 None None N
P/C 0.6362 likely_pathogenic 0.6306 pathogenic -0.732 Destabilizing 0.998 D 0.523 neutral None None None None N
P/D 0.7148 likely_pathogenic 0.741 pathogenic -0.931 Destabilizing 0.842 D 0.419 neutral None None None None N
P/E 0.3919 ambiguous 0.3934 ambiguous -1.024 Destabilizing 0.842 D 0.399 neutral None None None None N
P/F 0.7693 likely_pathogenic 0.7854 pathogenic -1.078 Destabilizing 0.974 D 0.538 neutral None None None None N
P/G 0.3903 ambiguous 0.4258 ambiguous -1.25 Destabilizing 0.842 D 0.425 neutral None None None None N
P/H 0.353 ambiguous 0.3494 ambiguous -0.73 Destabilizing 0.997 D 0.467 neutral N 0.486532612 None None N
P/I 0.4724 ambiguous 0.4858 ambiguous -0.655 Destabilizing 0.949 D 0.564 neutral None None None None N
P/K 0.3411 ambiguous 0.3474 ambiguous -0.893 Destabilizing 0.842 D 0.401 neutral None None None None N
P/L 0.2398 likely_benign 0.2301 benign -0.655 Destabilizing 0.669 D 0.413 neutral N 0.486279122 None None N
P/M 0.4911 ambiguous 0.479 ambiguous -0.441 Destabilizing 0.991 D 0.474 neutral None None None None N
P/N 0.4714 ambiguous 0.4892 ambiguous -0.597 Destabilizing 0.842 D 0.481 neutral None None None None N
P/Q 0.2088 likely_benign 0.2077 benign -0.893 Destabilizing 0.974 D 0.453 neutral None None None None N
P/R 0.2408 likely_benign 0.2366 benign -0.241 Destabilizing 0.934 D 0.493 neutral D 0.527019006 None None N
P/S 0.1875 likely_benign 0.1936 benign -0.994 Destabilizing 0.454 N 0.346 neutral N 0.494714587 None None N
P/T 0.1436 likely_benign 0.1354 benign -0.992 Destabilizing 0.007 N 0.131 neutral N 0.492829075 None None N
P/V 0.3148 likely_benign 0.3194 benign -0.752 Destabilizing 0.728 D 0.356 neutral None None None None N
P/W 0.838 likely_pathogenic 0.8497 pathogenic -1.147 Destabilizing 0.998 D 0.557 neutral None None None None N
P/Y 0.6872 likely_pathogenic 0.711 pathogenic -0.884 Destabilizing 0.991 D 0.538 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.